New drug cocktail aims to boost stroke recovery
NCT ID NCT07483281
First seen Mar 25, 2026 · Last updated May 09, 2026 · Updated 7 times
Summary
This study tests whether adding a drug called human urinary kallidinogenase (HUK) to standard clot-busting therapy (reteplase) helps people recover better after a stroke. About 220 adults who have had a moderate stroke within the last 4.5 hours will receive either the combination or standard treatment. The main goal is to see if more people are disability-free 90 days later.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE ISCHEMIC STROKE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
China-Japan Union Hospital of Jilin University
Changchun, Jilin, 130033, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact
Conditions
Explore the condition pages connected to this study.